Article
DPYD variants as predictors of 5-fluorouracil toxicity in adjuvant colon cancer treatment (NCCTG N0147).
Journal of the National Cancer Institute - 1 Dec 2014
Lee Adam M, Shi Qian, Pavey Emily, Alberts Steven R, Sargent Daniel J, Sinicrope Frank A, Berenberg Jeffrey L, Goldberg Richard M, Diasio Robert B
Abstract excerpt
BACKGROUND: Previous studies have suggested the potential importance of three DPYD variants (DPYD*2A, D949V, and I560S) with increased 5-FU toxicity. Their individual associations, however, in 5-FU-based combination therapies, remain controversial and require further systematic study in a large patient population receiving comparable treatment regimens with uniform clinical data. METHODS: We genotyped 2886 stage...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
